Shareholders Foundation, Inc.

Neovasc Inc. (NASDAQ:NVCN) Long Term Shareholder Notice: Investigation over Possible Wrongdoing

An investigation on behalf of current long term investors in Neovasc Inc. (NASDAQ:NVCN) shares over possible breaches of fiduciary duty by certain officers and directors was announced.

 

San Diego, CA -- (SBWIRE) -- 03/08/2021 -- An investigation was announced concerning potential breaches of fiduciary duties by certain directors of Neovasc Inc.

Investors who are current long term investors in Neovasc Inc. (NASDAQ: NVCN) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm for investors in NASDAQ: NVCN stocks follows a lawsuit filed against Neovasc Inc. over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: NVCN stocks, concerns whether certain Neovasc officers and directors are liable in connection with the allegations made in that lawsuit.

The plaintiff alleges that the Defendants failed to disclose to investors that the results of COSIRA, Neovasc's clinical study for the Reducer, contained imbalances in missing information present in the control group versus the treatment group, including significant missing information for secondary endpoints but none for the primary endpoint, that the imbalance in missing information indicated that control subjects were aware of their treatment assignment (not blinded) and less inclined to participate in additional data collection, that blinding is critical when studying a placebo-responsive condition such as angina, that the lack of blinding assessment made the primary endpoint difficult to interpret, that, as a result of the foregoing, the FDA was reasonably likely to require additional premarket clinical data, that, as a result, the Company's PMA for Reducer was unlikely to be approved without additional clinical data, and that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Those who purchased shares of Neovasc Inc. (NASDAQ: NVCN) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.